Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AstraZeneca Invests in Australian Mfg. Site | Contract Pharma

What are you searching for?

Sign in
Breaking News

AstraZeneca Invests in Australian Mfg. Site

To expand facility in Sydney suburb as demand for its respiratory medicines has grown

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AstraZeneca plans to invest $133 million in its Australian manufacturing site as demand for its respiratory medicines in China has grown. The company plans to expand its facility in Sydney suburb North Ryde, New South Wales, which will create 250 new jobs and increase the site’s annual exports to AU$4.4 billion over the next four years. This expansion follows the company’s $67 million investment in 2017 to grow the site.

AstraZeneca employs more than 1,000 people in Australia and New Zealand. The company also has an on-site commercial organization that spans corporate affairs, distribution, finance, and marketing. The Sydney site delivers medicines to Australia, Asia-Pacific countries and other markets globally.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics